Spots Global Cancer Trial Database for LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
Official Title: A Randomised, Open-label, Phase III Study to Evaluate the Efficacy and Safety of Oral Afatinib (BIBW 2992) Versus Intravenous Methotrexate in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Who Have Progressed After Platinum-based Therapy
Study ID: NCT01345682
Study Description
Brief Summary: This randomised, open-label, phase III study will be performed in patients with R/M head and neck squamous cell carcinoma (HNSCC) who have progressed after platinum-based therapy. The objectives of the trial are to compare the efficacy and safety of afatinib versus methotrexate
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
1200.43.00113 Boehringer Ingelheim Investigational Site, Harvey, Illinois, United States
1200.43.00106 Boehringer Ingelheim Investigational Site, Peoria, Illinois, United States
1200.43.00110 Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States
1200.43.00107 Boehringer Ingelheim Investigational Site, Omaha, Nebraska, United States
1200.43.00105 Boehringer Ingelheim Investigational Site, Stony Brook, New York, United States
1200.43.00102 Boehringer Ingelheim Investigational Site, Philadelphia, Pennsylvania, United States
1200.43.00103 Boehringer Ingelheim Investigational Site, Philadelphia, Pennsylvania, United States
1200.43.00109 Boehringer Ingelheim Investigational Site, San Antonio, Texas, United States
1200.43.05401 Boehringer Ingelheim Investigational Site, Ciudad Autonoma de Bs As, , Argentina
1200.43.05402 Boehringer Ingelheim Investigational Site, Santa Fe, , Argentina
1200.43.05403 Boehringer Ingelheim Investigational Site, Villa Dominico, , Argentina
1200.43.04303 Boehringer Ingelheim Investigational Site, Leoben, , Austria
1200.43.04305 Boehringer Ingelheim Investigational Site, Salzburg, , Austria
1200.43.04301 Boehringer Ingelheim Investigational Site, Wien, , Austria
1200.43.03202 Boehringer Ingelheim Investigational Site, Bruxelles, , Belgium
1200.43.03203 Boehringer Ingelheim Investigational Site, Edegem, , Belgium
1200.43.03204 Boehringer Ingelheim Investigational Site, Gent, , Belgium
1200.43.03201 Boehringer Ingelheim Investigational Site, Leuven, , Belgium
1200.43.05504 Boehringer Ingelheim Investigational Site, Barretos, , Brazil
1200.43.05505 Boehringer Ingelheim Investigational Site, Jau, , Brazil
1200.43.05507 Boehringer Ingelheim Investigational Site, Passo Fundo, , Brazil
1200.43.05503 Boehringer Ingelheim Investigational Site, Porto Alegre, , Brazil
1200.43.05502 Boehringer Ingelheim Investigational Site, Rio de Janeiro, , Brazil
1200.43.05501 Boehringer Ingelheim Investigational Site, Sao Paulo, , Brazil
1200.43.05506 Boehringer Ingelheim Investigational Site, Sao Paulo, , Brazil
1200.43.04202 Boehringer Ingelheim Investigational Site, Olomouc, , Czechia
1200.43.04203 Boehringer Ingelheim Investigational Site, Prague 2, , Czechia
1200.43.04201 Boehringer Ingelheim Investigational Site, Prague 8, , Czechia
1200.43.04501 Boehringer Ingelheim Investigational Site, København Ø, , Denmark
1200.43.03304 Boehringer Ingelheim Investigational Site, Avignon Cedex 9, , France
1200.43.03306 Boehringer Ingelheim Investigational Site, Clermont-Ferrand cedex 1, , France
1200.43.03312 Boehringer Ingelheim Investigational Site, Dijon Cedex, , France
1200.43.03303 Boehringer Ingelheim Investigational Site, Lille Cedex, , France
1200.43.03301 Boehringer Ingelheim Investigational Site, Lyon Cedex, , France
1200.43.03302 Boehringer Ingelheim Investigational Site, Montpellier cedex 5, , France
1200.43.03307 Boehringer Ingelheim Investigational Site, Nice cedex 2, , France
1200.43.03314 Boehringer Ingelheim Investigational Site, Paris Cedex 05, , France
1200.43.03305 Boehringer Ingelheim Investigational Site, Poitiers, , France
1200.43.03316 Boehringer Ingelheim Investigational Site, Rouen Cedex 1, , France
1200.43.03309 Boehringer Ingelheim Investigational Site, Saint Herblain Cedex, , France
1200.43.03310 Boehringer Ingelheim Investigational Site, Vandoeuvre les Nancy cedex, , France
1200.43.03317 Boehringer Ingelheim Investigational Site, Villejuif Cedex, , France
1200.43.04903 Boehringer Ingelheim Investigational Site, Aachen, , Germany
1200.43.04902 Boehringer Ingelheim Investigational Site, Berlin, , Germany
1200.43.04909 Boehringer Ingelheim Investigational Site, Dresden, , Germany
1200.43.04901 Boehringer Ingelheim Investigational Site, Essen, , Germany
1200.43.04905 Boehringer Ingelheim Investigational Site, Hamburg, , Germany
1200.43.04906 Boehringer Ingelheim Investigational Site, Hannover, , Germany
1200.43.04908 Boehringer Ingelheim Investigational Site, Jena, , Germany
1200.43.04904 Boehringer Ingelheim Investigational Site, Leipzig, , Germany
1200.43.04907 Boehringer Ingelheim Investigational Site, Mannheim, , Germany
1200.43.03004 Boehringer Ingelheim Investigational Site, Haidari, , Greece
1200.43.03005 Boehringer Ingelheim Investigational Site, Heraklion, , Greece
1200.43.03002 Boehringer Ingelheim Investigational Site, Thessaloniki, , Greece
1200.43.97201 Boehringer Ingelheim Investigational Site, Haifa, , Israel
1200.43.97203 Boehringer Ingelheim Investigational Site, Petach Tikva, , Israel
1200.43.97204 Boehringer Ingelheim Investigational Site, Tel Hashomer, , Israel
1200.43.03909 Boehringer Ingelheim Investigational Site, Aosta, , Italy
1200.43.03908 Boehringer Ingelheim Investigational Site, Cagliari, , Italy
1200.43.03901 Boehringer Ingelheim Investigational Site, Confreria (CN), , Italy
1200.43.03907 Boehringer Ingelheim Investigational Site, Milano, , Italy
1200.43.03903 Boehringer Ingelheim Investigational Site, Napoli, , Italy
1200.43.03905 Boehringer Ingelheim Investigational Site, Palermo, , Italy
1200.43.03902 Boehringer Ingelheim Investigational Site, Savona, , Italy
1200.43.03904 Boehringer Ingelheim Investigational Site, Taormina (ME), , Italy
1200.43.03906 Boehringer Ingelheim Investigational Site, Venezia, , Italy
1200.43.03910 Boehringer Ingelheim Investigational Site, Viterbo, , Italy
1200.43.08106 Boehringer Ingelheim Investigational Site, Aichi, Nagoya, , Japan
1200.43.08103 Boehringer Ingelheim Investigational Site, Chiba, Kashiwa, , Japan
1200.43.08108 Boehringer Ingelheim Investigational Site, Ehime, Matsuyama, , Japan
1200.43.08111 Boehringer Ingelheim Investigational Site, Hyogo, Akashi, , Japan
1200.43.08107 Boehringer Ingelheim Investigational Site, Hyogo, Kobe, , Japan
1200.43.08109 Boehringer Ingelheim Investigational Site, Kanagawa, Isehara, , Japan
1200.43.08114 Boehringer Ingelheim Investigational Site, Miyagi, Natori, , Japan
1200.43.08110 Boehringer Ingelheim Investigational Site, Osaka, Osaka, , Japan
1200.43.08105 Boehringer Ingelheim Investigational Site, Shizuoka, Sunto-gun, , Japan
1200.43.08102 Boehringer Ingelheim Investigational Site, Tochigi, Shimotsuke, , Japan
1200.43.08113 Boehringer Ingelheim Investigational Site, Tokyo, Koto-ku, , Japan
1200.43.08104 Boehringer Ingelheim Investigational Site, Tokyo, Meguro-ku, , Japan
1200.43.08112 Boehringer Ingelheim Investigational Site, Tokyo, Minato-ku, , Japan
1200.43.05202 Boehringer Ingelheim Investigational Site, Mexico, , Mexico
1200.43.00704 Boehringer Ingelheim Investigational Site, Ivanovo, , Russian Federation
1200.43.00706 Boehringer Ingelheim Investigational Site, Kurski, , Russian Federation
1200.43.00709 Boehringer Ingelheim Investigational Site, Moscow, , Russian Federation
1200.43.00703 Boehringer Ingelheim Investigational Site, Omsk, , Russian Federation
1200.43.00710 Boehringer Ingelheim Investigational Site, Pyatigorsk, , Russian Federation
1200.43.00707 Boehringer Ingelheim Investigational Site, St. Petersburg, , Russian Federation
1200.43.00705 Boehringer Ingelheim Investigational Site, Ufa, , Russian Federation
1200.43.02703 Boehringer Ingelheim Investigational Site, Cape Town, , South Africa
1200.43.02704 Boehringer Ingelheim Investigational Site, Kraaifontein, Cape Town, , South Africa
1200.43.02701 Boehringer Ingelheim Investigational Site, Parktown, Johannesburg, , South Africa
1200.43.02702 Boehringer Ingelheim Investigational Site, Pretoria, , South Africa
1200.43.03401 Boehringer Ingelheim Investigational Site, Barcelona, , Spain
1200.43.03404 Boehringer Ingelheim Investigational Site, Barcelona, , Spain
1200.43.03405 Boehringer Ingelheim Investigational Site, Girona, , Spain
1200.43.03406 Boehringer Ingelheim Investigational Site, Málaga, , Spain
1200.43.03402 Boehringer Ingelheim Investigational Site, Salamanca, , Spain
1200.43.03403 Boehringer Ingelheim Investigational Site, Zaragoza, , Spain
1200.43.04602 Boehringer Ingelheim Investigational Site, Göteborg, , Sweden
1200.43.04101 Boehringer Ingelheim Investigational Site, Basel, , Switzerland
1200.43.04102 Boehringer Ingelheim Investigational Site, Bern, , Switzerland
Contact Details
Name: Boehringer Ingelheim
Affiliation: Boehringer Ingelheim
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
